Volume 123, Issue 11 pp. 2684-2695
Cancer Therapy

Biophysical and biochemical characterization of a liposarcoma-derived recombinant MnSOD protein acting as an anticancer agent

Aldo Mancini

Corresponding Author

Aldo Mancini

Department of Molecular Biology and Biotherapy, National Cancer Institute “G. Pascale” Naples, Naples, Italy

Fax: 0039-081-5903720.

National Cancer Institute of Naples, Via Mariano Semmola 80131, Naples, ItalySearch for more papers by this author
Antonella Borrelli

Antonella Borrelli

Department of Molecular Biology and Biotherapy, National Cancer Institute “G. Pascale” Naples, Naples, Italy

Search for more papers by this author
Antonella Schiattarella

Antonella Schiattarella

Department of Molecular Biology and Biotherapy, National Cancer Institute “G. Pascale” Naples, Naples, Italy

Search for more papers by this author
Luigi Aloj

Luigi Aloj

Department of Nuclear Medicine, National Cancer Institute “G. Pascale” Naples, Naples, Italy

Search for more papers by this author
Michela Aurilio

Michela Aurilio

Department of Nuclear Medicine, National Cancer Institute “G. Pascale” Naples, Naples, Italy

Search for more papers by this author
Franco Morelli

Franco Morelli

Institute of Genetic and Biophysic.-A. Buzzati Traverso Naples, Naples, Italy

Search for more papers by this author
Alessandra Pica

Alessandra Pica

Department of Biological Science, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Antonella Occhiello

Antonella Occhiello

Department of Biological Science, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Roberto Lorizio

Roberto Lorizio

Department of Surgical Veterinary, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Roberto Mancini

Roberto Mancini

Department of Surgical Veterinary, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Alessandro Sica

Alessandro Sica

Department of Surgical Veterinary, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Lelio Mazzarella

Lelio Mazzarella

Department of Chemistry, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Filomena Sica

Filomena Sica

Department of Chemistry, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Paolo Grieco

Paolo Grieco

Department of Pharmacology and Toxicology, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Ettore Novellino

Ettore Novellino

Department of Pharmacology and Toxicology, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Daniela Pagnozzi

Daniela Pagnozzi

Department of Organic Chemistry, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Piero Pucci

Piero Pucci

Department of Organic Chemistry, University Federico II-Naples, Naples, Italy

Search for more papers by this author
Jean Rommelaere

Jean Rommelaere

Deutsches Krebsforschungszentrum, Infection and Cancer Program, Abt.F010 and INSERM U701, Heidelberg, Germany

Search for more papers by this author
First published: 16 September 2008
Citations: 21

Abstract

A recombinant MnSOD (rMnSOD) synthesized by specific cDNA clones derived from a liposarcoma cell line was shown to have the same sequence as the wild-type MnSOD expressed in the human myeloid leukaemia cell line U937, except for the presence of the leader peptide at the N-terminus. These results were fully confirmed by the molecular mass of rMnSOD as evaluated by ES/MS analysis (26662.7 Da) and the nucleotide sequence of the MnSOD cDNA. The role of the leader peptide in rMnSOD was investigated using a fluorescent and/or 68Gallium-labelled synthetic peptide. The labelled peptide permeated MCF-7 cells and uptake could be inhibited in the presence of an excess of oestrogen. In vivo it was taken up by the tumour, suggesting that the molecule can be used for both therapy and diagnosis. The in vitro and in vivo pharmacology tests confirmed that rMnSOD is only oncotoxic for tumour cells expressing oestrogen receptors. Pharmacokinetic studies in animals performed with 125I- and 131I-labelled proteins confirmed that, when administered systemically, rMnSOD selectively reached the tumour, where its presence was unambiguously demonstrated by scintigraphic and PET scans. PCR analysis revealed that Bax gene expression was increased and the Bcl2 gene was down regulated in MCF7 cells treated with rMnSOD, which suggests that the protein induces a pro-apoptotic mechanism. © 2008 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.